Shah Metacorp Intrinsic Value
Shah Metacorp (SHAH) median intrinsic value is ₹5.02 from 7 valuation models (range ₹2–₹13), vs current price ₹5.30 — -5.3% downside (Trading Near Calculated Value), margin of safety -5.6%. For current market price and key ratios, visit SHAH share price screener.
SHAH Valuation Methods Summary — DCF, Graham Number & P/E
Shah Metacorp intrinsic value across 7 models vs current price ₹5.30 — upside/downside and value range per method. Browse SHAH income statement for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1.59 | ₹1.27 - ₹1.91 | -70.0% | EPS: ₹0.04, Sector P/E: 12x |
| Book Value Method | asset | ₹13.25 | ₹11.93 - ₹14.58 | +150.0% | Book Value/Share: ₹27.97, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹10.60 | ₹9.54 - ₹11.66 | +100.0% | Revenue/Share: ₹45.42, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹8.14 | ₹7.33 - ₹8.95 | +53.6% | EBITDA: ₹8.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹1.59 | ₹1.43 - ₹1.75 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹1.59 | ₹1.43 - ₹1.75 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹5.02 | ₹4.52 - ₹5.52 | -5.3% | EPS: ₹0.04, BVPS: ₹27.97 |
SHAH Intrinsic Value vs Market Price — All Valuation Models
Shah Metacorp fair value range ₹2–₹13 vs current market price ₹5.30 across 7 valuation models. Also explore SHAH price trends to track price trends across different timeframes.
SHAH Intrinsic Value Analysis — Undervalued or Overvalued?
Shah Metacorp median intrinsic value ₹5.02, current price ₹5.30 — Trading Near Calculated Value by 5.3%, margin of safety -5.6%.
What is the intrinsic value of SHAH?
Based on our comprehensive analysis using 7 different valuation methods, the estimated intrinsic value of Shah Metacorp (SHAH) is ₹5.02 (median value). With the current market price of ₹5.30, this represents a -5.3% variance from our estimated fair value.
The valuation range spans from ₹1.59 to ₹13.25, indicating ₹1.59 - ₹13.25.
Is SHAH undervalued or overvalued?
Based on our multi-method analysis, Shah Metacorp (SHAH) appears to be trading near calculated value by approximately 5.3%.
SHAH Financial Health — Key Ratios vs Industry Benchmarks
Shah Metacorp financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 8.28 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 2.4% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 2.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.35x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
SHAH Cash Flow Quality — Operating & Free Cash Flow
Shah Metacorp operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-47 Cr | ₹-52 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-32 Cr | ₹-32 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹0 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-21 Cr | ₹-21 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹-11 Cr | ₹-11 Cr | Negative Cash Flow | 3/10 |